← Eichor
Study identifier: NCT07089836 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay Performance Versus Established Comparator Tests.

Condition: Treponema Pallidum · Treponema Pallidum Infection · Syphilis Infection  ·  Sponsor: American Laboratory Products Company

PhaseN/A
Planned participants1000
Who can joinAll sexes, 13 Years to no upper limit
Healthy volunteersYes

About this study

This study will evaluate the clinical performance of two investigational diagnostic kits developed by ALPCO: the Syphilis-T CLIA Kit and the Syphilis-NT CLIA Kit. These kits are designed to detect antibodies to Treponema pallidum and non-treponemal lipoidal antigens, respectively, in human serum and plasma using the automated KleeYa platform. The study will collect and analyze blood samples from individuals suspected of having syphilis, those at high risk, HIV-positive patients, pregnant individuals, and healthy controls. The aim is to determine the kits' Positive Percent Agreement (PPA) and Negative Percent Agreement (NPA) compared to established reference assays.

This description comes directly from the study's public registry record.

Talk to the study team

Yomi Ojutalayo  ·  800-592-5726  ·  clinops@alpco.com

Jim Richard  ·  800-592-5726  ·  regulatory@alpco.com

Always discuss trial participation with your own doctor first.

Locations (6)

Chemidox Clinical Trials CaliforniaLancaster, California, United StatesRecruiting
Folio Clinical ResearchLos Angeles, California, United StatesRecruiting
Segel TrialsNorth Miami, Florida, United StatesRecruiting
IMA Clinical Research - St.PetersburgSt. Petersburg, Florida, United StatesRecruiting
Chemidox Tx LLCHouston, Texas, United StatesRecruiting
VAST Clinical ResearchMesquite, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07089836